Unconfigured Ad
Collapse
Relevant events or scientific conferences that may be of interest to the community. (Mgmt reserves right to limit commercial content without approval.)
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by pacbio, 02-21-2020, 12:07 PM
|
0 responses
4,203 views
0 reactions
|
Last Post
by pacbio
02-21-2020, 12:07 PM
|
||
|
Started by Physalia-courses, 02-17-2020, 05:51 AM
|
0 responses
2,273 views
0 reactions
|
Last Post
|
||
|
Started by hollystephens723, 02-13-2020, 05:31 PM
|
0 responses
2,027 views
0 reactions
|
Last Post
|
||
|
Started by pacbio, 02-12-2020, 11:52 AM
|
0 responses
3,140 views
0 reactions
|
Last Post
by pacbio
02-12-2020, 11:52 AM
|
||
|
Started by Biotexcel, 02-12-2020, 07:52 AM
|
0 responses
4,021 views
0 reactions
|
Last Post
by Biotexcel
02-12-2020, 07:52 AM
|
||
|
Started by pacbio, 02-11-2020, 06:39 PM
|
0 responses
3,032 views
0 reactions
|
Last Post
by pacbio
02-11-2020, 06:39 PM
|
||
|
Started by plabaj, 02-11-2020, 06:54 AM
|
0 responses
3,913 views
0 reactions
|
Last Post
by plabaj
02-11-2020, 06:54 AM
|
||
|
Phase 2 Data Now Available for the precisionFDA & Georgetown Brain Cancer Challengeg
by hollystephens723
Started by hollystephens723, 02-06-2020, 04:57 PM
|
0 responses
1,824 views
0 reactions
|
Last Post
|
||
|
Started by ecSeq Bioinformatics, 02-05-2018, 10:27 AM
|
3 responses
8,325 views
0 reactions
|
Last Post
|
||
|
precisionFDA aBrain Cancer Predictive Modeling Challenge Extension and New Incentive
by hollystephens723
Started by hollystephens723, 01-29-2020, 08:45 AM
|
0 responses
3,089 views
0 reactions
|
Last Post
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is changing how clinical and public health laboratories detect pathogens, track antimicrobial resistance,...-
Channel: Webinar Series
10-01-2026, 05:37 AM -
-
by SEQadmin2
Much of the genetic basis of Alzheimer's disease and related dementias (AD/ADRD) is still unexplained, and some of the answers may sit...-
Channel: Webinar Series
10-01-2026, 05:06 AM -
Recent Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
-
by SEQadmin2
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...-
Channel: Articles
09-01-2026, 05:41 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 10:52 AM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
||
|
Started by SEQadmin2, 10-13-2026, 09:56 AM
|
0 responses
16 views
0 reactions
|
Last Post
by SEQadmin2
10-13-2026, 09:56 AM
|